CD267 Polyclonal Antibody

The TNF receptor superfamily member 13B encoded by TNFRSF13B is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17.

The CD267 Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and analysis of CD267 protein expression. This antibody is produced through a rigorous and meticulous process, ensuring its exceptional quality and reliability.

The CD267 Polyclonal Antibody exhibits a broad reactivity across various species, making it suitable for a wide range of applications in both research and clinical settings. It has been extensively validated for its specificity, exhibiting minimal cross-reactivity with other proteins, thus ensuring accurate and precise results.

This antibody demonstrates exceptional sensitivity, enabling the detection of even low levels of CD267 protein expression. Its high affinity and avidity contribute to its superior performance, allowing for reliable and reproducible results in various experimental conditions.

The CD267 Polyclonal Antibody is supplied in a convenient and user-friendly format, facilitating its easy integration into laboratory workflows. It is available in different sizes to accommodate diverse experimental needs.

With its exceptional specificity, sensitivity, and reliability, the CD267 Polyclonal Antibody is an indispensable tool for researchers and clinicians alike, enabling the elucidation of CD267 protein function and its potential implications in various biological processes and diseases.